During the past decade, Institutul Regional de Oncologie Iasi; Clinica de Hematologie conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institutul Regional de Oncologie Iasi; Clinica de Hematologie" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Institutul Regional de Oncologie Iasi; Clinica de Hematologie" are "Cancer" (1 trials), "Cancer of Unknown Primary Site" (1 trials), "Lymphocytic Leukemia, Chronic" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Institutul Regional de Oncologie Iasi; Clinica de Hematologie" in a lesser frequency.

Most popular intervention types in "Institutul Regional de Oncologie Iasi; Clinica de Hematologie" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Carboplatin" (3 trials), "Cisplatin" (3 trials), "Gemcitabine" (3 trials) and "Alectinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institutul Regional de Oncologie Iasi; Clinica de Hematologie" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Institutul Regional de Oncologie Iasi; Clinica de Hematologie". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Institutul Regional de Oncologie Iasi; Clinica de Hematologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Institutul Regional de Oncologie Iasi; Clinica de Hematologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".